Skin permeation of propranolol from polymeric film containing terpene enhancers for transdermal use

被引:104
作者
Amnuaikit, C
Ikeuchi, I
Ogawara, K
Higaki, K
Kimura, T [1 ]
机构
[1] Okayama Univ, Fac Pharmaceut Sci, Dept Pharmaceut, Okayama 7008530, Japan
[2] Prince Songkla Univ, Fac Pharmaceut Sci, Dept Pharmaceut Technol, Songkhla 90112, Thailand
关键词
propranolol hydrochloride; terpene; transdermal absorption; polymeric film; cineole; propylene glycol;
D O I
10.1016/j.ijpharm.2004.11.007
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
To develop the suitable film formulations of propranolol hydrochloride (PPL) containing enhancers for transdermal use, polymeric film formulations were prepared by employing ethyl cellulose (EC) and polyvinyl pyrrolidone (PVP) as a film former, and dibutyl phthalate (DBP) as a plasticizer. Terpenes such as menthol and cineole, and propylene glycol (PG) were also employed as a chemical enhancer to improve the skin penetration of PPL. The film preparations were characterized in physical properties such as uniformity of drug content, thickness and moisture uptake capacity. Release and skin permeation kinetics of PPL from film preparations were examined in the in vitro studies using a Franz-type diffusion cell. The uniformity of drug content was evidenced by the low S.D. values for each film preparation. The moisture uptake capacity and drug release rate increased with the increase of PVP in each preparation. Enhancers examined in the present study also increased the moisture uptake capacity and release rate of PPL from the film preparations. Increasing the concentration of PPL from 1 to 2 mg/cm(2) in the film enhanced the release rate of PPL, while no effect of enhancer concentrations on the release rate from the film preparations was observed. In vitro skin permeation study showed that cineole was the most promising enhancer among the enhancers examined in the present study and suggested that the suitable compositions of film preparation would be EC:PVP:PPL = 6:3:4 with 10% (w/w) cineole and 7:2:4 with 10% (w/w) PG and cineole, which provided high skin permeation rates at 93.81 +/- 11.56 and 54.51 +/- 0.52 mug/cm(2)/h, respectively. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:167 / 178
页数:12
相关论文
共 43 条
[31]   Reduction in skin permeation of N,N-diethyl-m-toluamide (DEET) by altering the skin/vehicle partition coefficient [J].
Ross, JS ;
Shah, JC .
JOURNAL OF CONTROLLED RELEASE, 2000, 67 (2-3) :211-221
[32]   Prediction of the plasma concentration profiles of orally administered drugs in rats on the basis of gastrointestinal transit kinetics and absorbability [J].
Sawamoto, T ;
Haruta, S ;
Kurosaki, Y ;
Higaki, K ;
Kimura, T .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1997, 49 (04) :450-457
[33]   Transdermal delivery of triprolidine using TPX polymer membrane [J].
Shin, SC ;
Kim, J ;
Yoon, MK ;
Oh, IJ ;
Choi, JS .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 235 (1-2) :141-147
[34]   Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC) [J].
Siepmann, J ;
Peppas, NA .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 48 (2-3) :139-157
[35]   Formula optimization based on artificial neural networks in transdermal drug delivery [J].
Takayama, K ;
Takahara, J ;
Fujikawa, M ;
Ichikawa, H ;
Nagai, T .
JOURNAL OF CONTROLLED RELEASE, 1999, 62 (1-2) :161-170
[36]  
*UN STAT PHARM, 1995, US PHARM COINV INC, P1327
[37]   Terpenes in ethanol: haloperidol permeation and partition through human skin and stratum corneum changes [J].
Vaddi, HK ;
Ho, PC ;
Chan, YW ;
Chan, SY .
JOURNAL OF CONTROLLED RELEASE, 2002, 81 (1-2) :121-133
[38]  
WALLE T, 1979, CLIN PHARMACOL THER, V26, P167
[39]   THE ENHANCEMENT INDEX CONCEPT APPLIED TO TERPENE PENETRATION ENHANCERS FOR HUMAN SKIN AND MODEL LIPOPHILIC (ESTRADIOL) AND HYDROPHILIC (5-FLUOROURACIL) DRUGS [J].
WILLIAMS, AC ;
BARRY, BW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1991, 74 (2-3) :157-168
[40]   TERPENES AND THE LIPID PROTEIN PARTITIONING THEORY OF SKIN PENETRATION ENHANCEMENT [J].
WILLIAMS, AC ;
BARRY, BW .
PHARMACEUTICAL RESEARCH, 1991, 8 (01) :17-24